Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion type Assertion NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_head.
- NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion description "[Taken together, these data strongly suggest that BRCA1-IRIS and/or BDNF/TrkB and NRG1/ErbB2 could serve as rational therapeutic targets for advanced ovarian cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_provenance.
- NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion evidence source_evidence_literature NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_provenance.
- NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion SIO_000772 25132263 NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_provenance.
- NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion wasDerivedFrom befree-2016 NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_provenance.
- NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_assertion wasGeneratedBy ECO_0000203 NP1211542.RAHNcmZn4kdgLayVJox5QM6ai_FPg-IZJtOdv7w9zWUYE130_provenance.